Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rudolf Hoermann

Showing results (51-60 of 97) with videos related to

Pageof 10
Sort By:
Clinical Endocrinology|June 30, 2015
Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetesEmily J Gianatti, Rudolf Hoermann, Que Lam, et al.
International Journal of Obesity (2005)|January 10, 2019
A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese menRudolf Hoermann, Mark Ng Tang Fui, Jesse C Krakauer, et al.
European Journal of Clinical Investigation|December 10, 2019
Triiodothyronine secretion in early thyroid failure: The adaptive response of central feedforward controlRudolf Hoermann, Mark J Pekker, John E M Midgley, et al.
Frontiers in Endocrinology|June 27, 2022
Principles of Endocrine Regulation: Reconciling Tensions Between Robustness in Performance and Adaptation to ChangeRudolf Hoermann, Mark J Pekker, John E M Midgley, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2025
Response to Letter to the Editor From Sumi and Tominaga: "Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial"Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2025
Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Scientific Reports|June 16, 2018
Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trialMark Ng Tang Fui, Rudolf Hoermann, Brendan Nolan, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 9, 2021
Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trialAda S Cheung, Rudolf Hoermann, Jasmine Zhu, et al.
Clinical Endocrinology|May 26, 2017
Effects of androgen deprivation therapy on telomere lengthAda S Cheung, Bu B Yeap, Rudolf Hoermann, et al.
European Journal of Endocrinology|June 25, 2016
Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancerAda S Cheung, Rudolf Hoermann, Philippe Dupuis, et al.
Pageof 10

Showing results (51-60 of 97) with videos related to

Sort By:
Pageof 10
Clinical Endocrinology|June 30, 2015
Effect of testosterone treatment on cardiac biomarkers in a randomized controlled trial of men with type 2 diabetesEmily J Gianatti, Rudolf Hoermann, Que Lam, et al.
International Journal of Obesity (2005)|January 10, 2019
A body shape index (ABSI) reflects body composition changes in response to testosterone treatment in obese menRudolf Hoermann, Mark Ng Tang Fui, Jesse C Krakauer, et al.
European Journal of Clinical Investigation|December 10, 2019
Triiodothyronine secretion in early thyroid failure: The adaptive response of central feedforward controlRudolf Hoermann, Mark J Pekker, John E M Midgley, et al.
Frontiers in Endocrinology|June 27, 2022
Principles of Endocrine Regulation: Reconciling Tensions Between Robustness in Performance and Adaptation to ChangeRudolf Hoermann, Mark J Pekker, John E M Midgley, et al.
The Journal of Clinical Endocrinology and Metabolism|October 1, 2025
Response to Letter to the Editor From Sumi and Tominaga: "Tolvaptan vs Fluid Restriction in Moderate-Profound Hyponatremia: An Open-Label Randomized Clinical Trial"Annabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2025
Tolvaptan versus fluid restriction in moderate-profound hyponatremia: An open-label randomized clinical trialAnnabelle M Warren, Mathis Grossmann, Rudolf Hoermann, et al.
Scientific Reports|June 16, 2018
Effect of testosterone treatment on bone remodelling markers and mineral density in obese dieting men in a randomized clinical trialMark Ng Tang Fui, Rudolf Hoermann, Brendan Nolan, et al.
Therapeutic Advances in Endocrinology and Metabolism|June 9, 2021
Zoledronic acid does not affect insulin resistance in men receiving androgen deprivation therapy: a prespecified secondary analysis of a randomised controlled trialAda S Cheung, Rudolf Hoermann, Jasmine Zhu, et al.
Clinical Endocrinology|May 26, 2017
Effects of androgen deprivation therapy on telomere lengthAda S Cheung, Bu B Yeap, Rudolf Hoermann, et al.
European Journal of Endocrinology|June 25, 2016
Relationships between insulin resistance and frailty with body composition and testosterone in men undergoing androgen deprivation therapy for prostate cancerAda S Cheung, Rudolf Hoermann, Philippe Dupuis, et al.
Pageof 10